Haemonetics (HAE) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.78 +0.34%
EPS Growth %: -0.9%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -0.9%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $1.31, $0.06 better than the analyst estimate of $1.25. Revenue for the quarter came in at $338.97 million versus the consensus estimate of $331.91 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Goldman Sachs Assumes Braze Inc (BRZE) at Buy
- BMO Capital Upgrades CES Energy Solutions Corp. (CEU:CN) (CESDF) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
